Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Search Results for "molecule":

Results: 1,776

Quotes

MLCL Molecule Holdings Inc Stock - CSE equities MLCL Molecule Holdings Inc Stock - CBOE Canada equities
Show all (2)

News

Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
By Investing.com

WATERTOWN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using...

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
By Investing.com

CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
By Investing.com

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its...

Show all (1,341)

Analysis

Immunogen Inks Deal With Jazz Pharma To Develop ADC Molecule
By Zacks Investment Research

ImmunoGen Inc. (NASDAQ:SASY) and Takeda. ImmunoGen, Inc. Price ImmunoGen, Inc. Price | ImmunoGen, Inc. QuoteZacks RankImmunoGen currently carries a Zacks Rank #3 (Hold). You can see the complete...

Achillion Pharmaceuticals Moving Ahead
By Edison

Moving ahead with Factor-D in rare diseasesThanks to its strong balance sheet following the out-licensing deal with Janssen in May 2015, Achillion Pharmaceuticals Inc (O:ACHN) appears to be well...

Oryzon Genomics - Initiation Of Coverage
By Edison

Oryzon’s core expertise lies in developing small molecule inhibitors for epigenetic targets. The company has advanced its lead compound ORY-1001 to a Phase I/IIa trial in acute leukaemia...

Show all (433)
Results: 2

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 1,341

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 433

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email